The 2026 British Association for Sexual Health and HIV (BASHH) guidelines for the management of viral hepatitis are in line with current evidence and practice within the United Kingdom. We provide evidence-based recommendations for the prevention, diagnosis and initial management of viral hepatitis A, B, C and D. Key updates are detailed at the start of the article.
European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol2017; 67: 370–398. https://doi.org/10.1016/j.jhep.2017.03.021
2.
European Association for the Study of the LiverClinical Practice Guidelines Panel ChairEASL Governing Board representative, et al.EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol2020; 73: 1170–1218. https://doi.org/10.1016/j.jhep.2020.08.018
BrookGBrockmeyerNvan de LaarT, et al.2017 European guideline for the screening, prevention and initial management of hepatitis B and C infections in sexual health settings. Int J STD AIDS2018; 29: 949–967. https://doi.org/10.1177/0956462418767576
5.
WilkinsENelsonMAgarwalK, et al.British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. HIV Med2013; 14(Suppl 4): 1–71. https://doi.org/10.1111/hiv.12106
6.
TerraultNALokASFMcMahonBJ, et al.Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology2018; 67: 1560–1599. https://doi.org/10.1002/hep.29800
7.
BhattacharyaDAronsohnAPriceJ, et al.Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection. Clin Infect Dis2023, Online ahead of print.
8.
GerettiAMBrookGCameronC, et al.British HIV Association Guidelines on the use of vaccines in HIV-positive adults 2015. HIV Med2016; 17 Suppl 3: s2–s81. https://doi.org/10.1111/hiv.12424
GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol2022; 7: 796–829. https://doi.org/10.1016/S2468-1253(22)00124-8
O'RiordanMGohLLambaH. Increasing hepatitis A IgG prevalence rate in men who have sex with men attending a sexual health clinic in London: implications for immunization policy. Int J STD AIDS2007; 18: 707–710. https://doi.org/10.1258/095646207782193902
15.
Le TurnierPCharreauIGabassiA, et al.Hepatitis A and B vaccine uptake and immunisation among men who have sex with men seeking PrEP: a substudy of the ANRS IPERGAY trial. Sex Transm Infect2023; 99: 140–142. https://doi.org/10.1136/sextrans-2022-055634
16.
ChenGJLinKYSunHY, et al.Incidence of acute hepatitis A among HIV-positive patients during an outbreak among MSM in Taiwan: impact of HAV vaccination. Liver Int2018; 38: 594–601. https://doi.org/10.1111/liv.13468
17.
ReganDGWoodJGBeneventC, et al.Estimating the critical immunity threshold for preventing hepatitis A outbreaks in men who have sex with men. Epidemiol Infect2016; 144: 1528–1537. https://doi.org/10.1017/S0950268815002605
18.
TheetenHVan HerckKVan Der MeerenO, et al.Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions. Vaccine2015; 33: 5723–5727. https://doi.org/10.1016/j.vaccine.2015.07.008
19.
KourkountiSPapaizosVLeuowK, et al.Hepatitis A vaccination and immunological parameters in HIV-infected patients. Viral Immunol2013; 26: 357–363. https://doi.org/10.1089/vim.2012.0100
20.
MenaGGarcia-BasteiroALLlupiaA, et al.Factors associated with the immune response to hepatitis A vaccination in HIV-infected patients in the era of highly active antiretroviral therapy. Vaccine2013; 31: 3668–3674. https://doi.org/10.1016/j.vaccine.2013.06.012
21.
Van DammePVan HerckK. A review of the long-term protection after hepatitis A and B vaccination. Travel Med Infect Dis2007; 5: 79–84. https://doi.org/10.1016/j.tmaid.2006.04.004
22.
NelsonNPWengMKHofmeisterMG, et al.Prevention of Hepatitis A virus infection in the United States: recommendations of the Advisory Committee on immunization practices, 2020. MMWR Recomm Rep2020; 69: 1–38. https://doi.org/10.15585/mmwr.rr6905a1
23.
Rendi-WagnerPKorinekMWinklerB, et al.Persistence of seroprotection 10 years after primary hepatitis A vaccination in an unselected study population. Vaccine2007; 25: 927–931. https://doi.org/10.1016/j.vaccine.2006.08.044
GilsonRJCde RuiterAWaiteJ, et al.Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage. Sex Transm Infect1998; 74: 110–115. https://doi.org/10.1136/sti.74.2.110
26.
StruveJGieseckeJLindhG, et al.Heterosexual contact as a major route for transmission of acute hepatitis B among adults. J Infect1990; 20: 111–121. https://doi.org/10.1016/0163-4453(90)93288-4
27.
HyamsKCPhillipsIATejadaA, et al.Hepatitis B in a highly active prostitute population: evidence for a low risk of chronic antigenemia. J Infect Dis1990; 162: 295–298. https://doi.org/10.1093/infdis/162.2.295
28.
KoffRSSlavinMMConnellyJD, et al.Contagiousness of acute hepatitis B. Secondary attack rates in household contacts. Gastroenterology1977; 72: 297–300.
29.
WardHDaySWeberJ. Risky business: health and safety in the sex industry over a 9 year period. Sex Transm Infect1999; 75: 340–343. https://doi.org/10.1136/sti.75.5.340
30.
WuJCChenCMSheenIJ, et al.Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology1995; 22: 1656–1660.
31.
HuoTIWuJCHuangYH, et al.Evidence of transmission of hepatitis B virus to spouses from sequence analysis of the viral genome. J Gastroenterol Hepatol1998; 13: 1138–1142. https://doi.org/10.1111/j.1440-1746.1998.tb00590.x
32.
PalmovićDCrnjaković-PalmovićJ. Prevention of hepatitis B virus (HBV) infection in health-care workers after accidental exposure: a comparison of two prophylactic schedules. Infection1993; 21: 42–45. https://doi.org/10.1007/BF01739311
33.
VogtTMPerzJFVan HoutenCKJr., et al.An outbreak of hepatitis B virus infection among methamphetamine injectors: the role of sharing injection drug equipment. Addiction2006; 101: 726–730. https://doi.org/10.1111/j.1360-0443.2006.01407.x
34.
WalshBMaguireHCarringtonD. Outbreak of hepatitis B in an acupuncture clinic. Commun Dis Public Health1999; 2: 137–140.
de SilvaTIGreenSTColeJ, et al.Successful use of Fendrix in HIV-infected non-responders to standard hepatitis B vaccines. J Infect2014; 68: 397–399. https://doi.org/10.1016/j.jinf.2013.12.009
38.
HoebeCJVermeirenAPDukers-MuijrersNH. Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders. Vaccine2012; 30: 6734–6737. https://doi.org/10.1016/j.vaccine.2012.08.074
HyerRNJanssenR. 2287. Recently approved HEPLISAV-B(R) [Hepatitis B vaccine (recombinant), adjuvanted] Shows a higher proportion of subjects achieving seroprotection with a more consistent immune response compared with Engerix-B(R) [Hepatitis B vaccine (Recombinant)] in three comparative trials. Open Forum Infect Dis2018; 5: S677–S678. https://doi.org/10.1093/ofid/ofy210.1940
42.
MarksKMKangMUmblejaT, et al.Immunogenicity and safety of Hepatitis B Virus (HBV) vaccine with a toll-like receptor 9 agonist adjuvant in HBV vaccine-naive people with human immunodeficiency virus. Clin Infect Dis2023; 77: 414–418. https://doi.org/10.1093/cid/ciad201
43.
SchnittmanSZepfRCocohobaJ, et al.21. Current and Nadir CD4+ counts are associated with Heplisav-B seroprotection rates in people with HIV. Open Forum Infect Dis2020; 7: S33–S35. https://doi.org/10.1093/ofid/ofaa439.066
44.
van der SandeMAMendyMWaightP, et al.Similar long-term vaccine efficacy of two versus three doses of HBV vaccine in early life. Vaccine2007; 25: 1509–1512. https://doi.org/10.1016/j.vaccine.2006.10.023
45.
WistromJAhlmCLundbergS, et al.Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine1999; 17: 2162–2165. https://doi.org/10.1016/s0264-410x(99)00012-2
46.
FonsecaMOPangLWde Paula CavalheiroN, et al.Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine2005; 23: 2902–2908. https://doi.org/10.1016/j.vaccine.2004.11.057
47.
OvertonETSungkanuparphSPowderlyWG, et al.Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis2005; 41: 1045–1048. https://doi.org/10.1086/433180
48.
PaitoonpongLSuankratayC. Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy. Scand J Infect Dis2008; 40: 54–58. https://doi.org/10.1080/00365540701522975
ZuckermanJN. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol2007; 79: 919–921. https://doi.org/10.1002/jmv.20816
51.
AhmedSMVolpellierMForsterG. The use of the super accelerated hepatitis B vaccination regimen in a north London sexual assault referral centre (SARC). J Forensic Leg Med2007; 14: 72–74. https://doi.org/10.1016/j.jcfm.2006.02.018
52.
BaralSShermanSGMillsonP, et al.Vaccine immunogenicity in injecting drug users: a systematic review. Lancet Infect Dis2007; 7: 667–674. https://doi.org/10.1016/S1473-3099(07)70237-2
53.
ConnorBABlatterMMBeranJ, et al.Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule. J Travel Med2007; 14: 9–15. https://doi.org/10.1111/j.1708-8305.2006.00106.x
54.
KallinowskiBJilgWBuchholzL, et al.Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C. Z Gastroenterol2003; 41: 983–990. https://doi.org/10.1055/s-2003-42929
55.
KeystoneJSHersheyJH. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule. Int J Infect Dis2008; 12: 3–11. https://doi.org/10.1016/j.ijid.2007.04.012
56.
MastEEWeinbaumCMFioreAE, et al.A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep2006; 55: 1–33; quiz CE31-34.
RobertsRJPalmerSR. Exposure to school children as a risk factor in a community outbreak of hepatitis A in young adults: a case control study. Epidemiol Infect2006; 134: 803–807. https://doi.org/10.1017/S0950268805005625
59.
Botelho-NeversEGautretP. Outbreaks associated to large open air festivals, including music festivals, 1980 to 2012. Euro Surveill2013; 18: 20426. https://doi.org/10.2807/ese.18.11.20426-en
RoweSLTannerKGregoryJE. Hepatitis A outbreak epidemiologically linked to a food handler in Melbourne, Victoria. Commun Dis Intell Q Rep2009; 33: 46–48.
62.
SchmidDFretzRBuchnerG, et al.Foodborne outbreak of hepatitis A, November 2007-January 2008, Austria. Eur J Clin Microbiol Infect Dis2009; 28: 385–391. https://doi.org/10.1007/s10096-008-0633-0
BellANcubeFHansellA, et al.An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health2001; 4: 163–170.
66.
CotterSMSansomSLongT, et al.Outbreak of hepatitis A among men who have sex with men: implications for hepatitis A vaccination strategies. J Infect Dis2003; 187: 1235–1240. https://doi.org/10.1086/374057
67.
DodgeBReeceMHerbenickD, et al.Relations between sexually transmitted infection diagnosis and sexual compulsivity in a community-based sample of men who have sex with men. Sex Transm Infect2008; 84: 324–327. https://doi.org/10.1136/sti.2007.028696
68.
ReintjesRBosmanAde ZwartO, et al.Outbreak of hepatitis A in Rotterdam associated with visits to 'darkrooms' in gay bars. Commun Dis Public Health1999; 2: 43–46.
69.
Stene-JohansenKTjonGSchreierE, et al.Molecular epidemiological studies show that hepatitis A virus is endemic among active homosexual men in Europe. J Med Virol2007; 79: 356–365. https://doi.org/10.1002/jmv.20781
70.
UrbanusATvan HoudtRvan de LaarTJ, et al.Viral hepatitis among men who have sex with men, epidemiology and public health consequences. Euro Surveill2009; 14: 19421. https://doi.org/10.2807/ese.14.47.19421-en
71.
Van RijckevorselGGSonderGJBoveeLP, et al.Trends in hepatitis A, B, and shigellosis compared with gonorrhea and syphilis in men who have sex with men in Amsterdam, 1992-2006. Sex Transm Dis2008; 35: 930–934. https://doi.org/10.1097/OLQ.0b013e3181812cdf
72.
RossJDGhanemMTariqA, et al.Seroprevalence of hepatitis A immunity in male genitourinary medicine clinic attenders: a case control study of heterosexual and homosexual men. Sex Transm Infect2002; 78: 174–179. https://doi.org/10.1136/sti.78.3.174
73.
GallegoMRoblesMPalaciosR, et al.Impact of acute hepatitis A virus (HAV) infection on HIV viral load in HIV-Infected patients and influence of HIV infection on acute HAV infection. J Int Assoc Physicians AIDS Care (Chic)2011; 10: 40–42. https://doi.org/10.1177/1545109710385692
74.
IdaSTachikawaNNakajimaA, et al.Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clin Infect Dis2002; 34: 379–385. https://doi.org/10.1086/338152
75.
LeeYLChenGJChenNY, et al.Less severe but prolonged course of acute hepatitis A in human immunodeficiency virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: a multicenter observational study. Clin Infect Dis2018; 67: 1595–1602. https://doi.org/10.1093/cid/ciy328
76.
NguiSLGranerodJJewesLA, et al.Outbreaks of hepatitis A in England and Wales associated with two co-circulating hepatitis A virus strains. J Med Virol2008; 80: 1181–1188. https://doi.org/10.1002/jmv.21207
LemonSMOttJJVan DammeP, et al.Type A viral hepatitis: a summary and update on the molecular virology, epidemiology, pathogenesis and prevention. J Hepatol2017, Online ahead of print. https://doi.org/10.1016/j.jhep.2017.08.034
79.
O'DonovanDCookeRPJoceR, et al.An outbreak of hepatitis A amongst injecting drug users. Epidemiol Infect2001; 127: 469–473. https://doi.org/10.1017/s0950268801006185
80.
BohmSRBergerKWHackertPB, et al.Hepatitis A outbreak among adults with developmental disabilities in group homes -Michigan, 2013. MMWR Morb Mortal Wkly Rep2015; 64: 148–152.
81.
RuscherCFaberMWerberD, et al.Resurgence of an international hepatitis A outbreak linked to imported frozen strawberries, Germany, 2018 to 2020. Euro Surveill2020; 25: 1900670. https://doi.org/10.2807/1560-7917.ES.2020.25.37.1900670
SookoianS. Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol2006; 5: 231–236.
86.
ElinavEBen-DovIZShapiraY, et al.Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology2006; 130: 1129–1134. https://doi.org/10.1053/j.gastro.2006.01.007
LeeHKKimKALeeJS, et al.Window period of anti-hepatitis A virus immunoglobulin M antibodies in diagnosing acute hepatitis A. Eur J Gastroenterol Hepatol2013; 25: 665–668. https://doi.org/10.1097/MEG.0b013e32835df262
89.
European Association for the Study of the Liver, Clinical Practice Guidelines PanelWendonJ, et al.EASL clinical practical guidelines on the management of acute (fulminant) liver failure. J Hepatol2017; 66: 1047–1081. https://doi.org/10.1016/j.jhep.2016.12.003
YeungLTRobertsEA. Hepatitis B in childhood: an update for the paediatrician. Paediatr Child Health2001; 6: 655–659. https://doi.org/10.1093/pch/6.9.655
CrampMEGrundyHCPerinpanayagamRM, et al.Seroprevalence of hepatitis B and C virus in two institutions caring for mentally handicapped adults. J R Soc Med1996; 89: 401–402.
101.
WallaceRA. Clinical audit of gastrointestinal conditions occurring among adults with Down syndrome attending a specialist clinic. J Intellect Dev Disabil2007; 32: 45–50. https://doi.org/10.1080/13668250601146761
National Institute for Health and Care Excellence (NICE). Hepatitis B (chronic): diagnosis and management. Clinical guideline [CG165]. https://www.nice.org.uk/guidance/cg165 (2013, updated 20 October 2017, accessed 28 January 2025).
OxmanADScottEASellorsJW, et al.Partner notification for sexually transmitted diseases: an overview of the evidence. Can J Public Health1994; 85(Suppl 1): S41–S47.
106.
McCleanHRadcliffeKSullivanA, et al.2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS2013; 24: 253–261. https://doi.org/10.1177/0956462412472804
107.
LandrumMLFiebergAMChunHM, et al.The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults. PLoS One2010; 5: e8687. https://doi.org/10.1371/journal.pone.0008687
ImYRJagdishRLeithD, et al.Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol2022; 7: 932–942. https://doi.org/10.1016/S2468-1253(22)00201-1
110.
RaimondoGLocarniniSPollicinoT, et al.Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol2019; 71: 397–408. https://doi.org/10.1016/j.jhep.2019.03.034
111.
SagnelliECoppolaNPisaturoM, et al.Clinical and virological improvement of hepatitis B virus-related or hepatitis C virus-related chronic hepatitis with concomitant hepatitis A virus infection. Clin Infect Dis2006; 42: 1536–1543. https://doi.org/10.1086/503840
112.
FattovichGBortolottiFDonatoF. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol2008; 48: 335–352. https://doi.org/10.1016/j.jhep.2007.11.011
113.
LinLVerslypeCvan PeltJF, et al.Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses. Eur J Gastroenterol Hepatol2006; 18: 1311–1319. https://doi.org/10.1097/01.meg.0000243881.09820.09
114.
ChiaramonteMStroffoliniTVianA, et al.Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer1999; 85: 2132–2137.
115.
PapatheodoridisGVManolakopoulosSDusheikoG, et al.Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet Infect Dis2008; 8: 167–178. https://doi.org/10.1016/S1473-3099(07)70264-5
ThomasHC. Best practice in the treatment of chronic hepatitis B: a summary of the European Viral Hepatitis Educational Initiative (EVHEI). J Hepatol2007; 47: 588–597. https://doi.org/10.1016/j.jhep.2007.07.017
118.
ThioCLSeabergECSkolaskyRJr., et al.HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet2002; 360: 1921–1926. https://doi.org/10.1016/s0140-6736(02)11913-1
119.
GerettiAMAustinHVillaG, et al.Hepatitis B virus infection in general practice across England: an analysis of the Royal College of General Practitioners Research and Surveillance Centre real-world database. J Infect2023; 86: 476–485. https://doi.org/10.1016/j.jinf.2023.03.001
120.
HuttonDWToyMSalomonJA, et al.Cost-effectiveness of hepatitis B testing and vaccination of adults seeking care for sexually transmitted infections. Sex Transm Dis2022; 49: 517–525. https://doi.org/10.1097/OLQ.0000000000001632
121.
ConnersEEPanagiotakopoulosLHofmeisterMG, et al.Screening and testing for hepatitis B virus infection: CDC recommendations - united States, 2023. MMWR Recomm Rep2023; 72: 1–25. https://doi.org/10.15585/mmwr.rr7201a1
World Health Organisation. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. https://www.who.int/publications/i/item/9789240090903 (2024, accessed 03 February 2025).
128.
BradyMRodgerAAsboeD, et al.BHIVA/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. HIV Med2019; 20 Suppl 2: s2–s80. https://doi.org/10.1111/hiv.12718
129.
British Viral Hepatitis Group (BVHG) and Maternal and Paediatric Subgroup. Guideline for the management of hepatitis B in pregnancy and the exposed infant. https://www.basl.org.uk/uploads/BVHGPerinatalHBV3.3.21.pdf (2021, accessed 29 January 2025).
PapatheodoridisGDalekosGSypsaV, et al.PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. J Hepatol2016; 64: 800–806. https://doi.org/10.1016/j.jhep.2015.11.035
DaBLHellerTKohC. Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterol Rep (Oxf)2019; 7: 231–245. https://doi.org/10.1093/gastro/goz023
134.
UrbanSNeumann-HaefelinCLamperticoP. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut2021; 70: 1782–1794. https://doi.org/10.1136/gutjnl-2020-323888
National Institute for Health and Care Excellence (NICE). Bulevirtide for treating chronic hepatitis D. Technology appraisal guidance [TA896]. https://www.nice.org.uk/guidance/ta896/evidence (2023, accessed 28 January 2025).
137.
Collaborators Polaris Observatory HCV. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study. Lancet Gastroenterol Hepatol2022; 7: 396–415. https://doi.org/10.1016/S2468-1253(21)00472-6
HedskogCParhyBChangS, et al.Identification of 19 novel hepatitis C virus subtypes-further expanding HCV classification. Open Forum Infect Dis2019; 6: ofz076. https://doi.org/10.1093/ofid/ofz076
142.
SonderupMWAfiheneMAllyR, et al.Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. Lancet Gastroenterol Hepatol2017; 2: 910–919. https://doi.org/10.1016/S2468-1253(17)30249-2
143.
VandelliCRenzoFRomanoL, et al.Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol2004; 99: 855–859. https://doi.org/10.1111/j.1572-0241.2004.04150.x
144.
TerraultNADodgeJLMurphyEL, et al.Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study. Hepatology2013; 57: 881–889. https://doi.org/10.1002/hep.26164
145.
MarincovichBCastillaJdel RomeroJ, et al.Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples. Sex Transm Infect2003; 79: 160–162. https://doi.org/10.1136/sti.79.2.160
146.
McMahonJMPougetERTortuS. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis. J Infect Dis2007; 195: 1572–1581. https://doi.org/10.1086/516785
147.
KaoJHLiuCJChenPJ, et al.Low incidence of hepatitis C virus transmission between spouses: a prospective study. J Gastroenterol Hepatol2000; 15: 391–395. https://doi.org/10.1046/j.1440-1746.2000.02165.x
148.
TohmeRAHolmbergSD. Is sexual contact a major mode of hepatitis C virus transmission?Hepatology2010; 52: 1497–1505. https://doi.org/10.1002/hep.23808
149.
JinFDoreGJMatthewsG, et al.Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol2021; 6: 39–56. https://doi.org/10.1016/S2468-1253(20)30303-4
150.
van de LaarTJvan der BijAKPrinsM, et al.Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis2007; 196: 230–238. https://doi.org/10.1086/518796
151.
BrowneRAsboeDGilleeceY, et al.Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?Sex Transm Infect2004; 80: 326–327. https://doi.org/10.1136/sti.2003.008532
152.
DantaMBrownDBhaganiS, et al.Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS2007; 21: 983–991. https://doi.org/10.1097/QAD.0b013e3281053a0c
153.
MarcellinFLorenteNDemoulinB, et al.Comparison of risk factors in HIV-infected men who have sex with men, coinfected or not with hepatitis C virus (ANRS VESPA2 French cross-sectional national survey). Sex Transm Infect2015; 91: 21–23. https://doi.org/10.1136/sextrans-2014-051542
154.
WardHMartinIMacdonaldN, et al.Lymphogranuloma venereum in the United Kingdom. Clin Infect Dis2007; 44: 26–32. https://doi.org/10.1086/509922
155.
Recently acquired and early chronic hepatitis C in MSM: recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel. AIDS2020; 34: 1699–1711.
156.
Hosseini-HooshyarSHajarizadehBBajisS, et al.Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression. Lancet HIV2022; 9: e414–e427. https://doi.org/10.1016/S2352-3018(22)00077-7
157.
GarveyLJCookeGSSmithC, et al.Decline in Hepatitis C Virus (HCV) incidence in men who have sex with men living with human immunodeficiency virus: progress to HCV microelimination in the United Kingdom?Clin Infect Dis2021; 72: 233–238. https://doi.org/10.1093/cid/ciaa021
158.
BoerekampsAvan den BerkGELauwFN, et al.Declining Hepatitis C Virus (HCV) incidence in Dutch human immunodeficiency virus-positive men who have sex with men after unrestricted access to HCV therapy. Clin Infect Dis2018; 66: 1360–1365. https://doi.org/10.1093/cid/cix1007
159.
KusejkoKSalazar-VizcayaLShahC, et al.Sustained effect on Hepatitis C elimination among men who have sex with men in the Swiss HIV cohort study: a systematic Re-Screening for hepatitis C RNA two years following a nation-wide elimination program. Clin Infect Dis2022; 75: 1723–1731. https://doi.org/10.1093/cid/ciac273
160.
DesaiMWhiteEVoraN, et al.High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre-exposure prophylaxis. J Viral Hepat2020; 27: 852–857. https://doi.org/10.1111/jvh.13297
161.
BradshawDVasylyevaTIDavisC, et al.Transmission of hepatitis C virus in HIV-positive and PrEP-using MSM in England. J Viral Hepat2020; 27: 721–730. https://doi.org/10.1111/jvh.13286
162.
AdesAEGordonFScottK, et al.Overall vertical transmission of hepatitis C virus, transmission net of clearance, and timing of transmission. Clin Infect Dis2023; 76: 905–912. https://doi.org/10.1093/cid/ciac270
163.
BenovaLMohamoudYACalvertC, et al.Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis2014; 59: 765–773. https://doi.org/10.1093/cid/ciu447
164.
OhtoHTerazawaSSasakiN, et al.Transmission of hepatitis C virus from mothers to infants. The vertical transmission of Hepatitis C virus collaborative study group. N Engl J Med1994; 330: 744–750. https://doi.org/10.1056/NEJM199403173301103
165.
MastEEHwangLYSetoDS, et al.Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis2005; 192: 1880–1889. https://doi.org/10.1086/497701
166.
CeciOMargiottaMMarelloF, et al.Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr2001; 33: 570–575. https://doi.org/10.1097/00005176-200111000-00011
167.
AzzariCMoriondoMIndolfiG, et al.Higher risk of hepatitis C virus perinatal transmission from drug user mothers is mediated by peripheral blood mononuclear cell infection. J Med Virol2008; 80: 65–71. https://doi.org/10.1002/jmv.21023
168.
Hepatitis B or C infections and breastfeeding | breastfeeding special circumstances | CDC (accessed 2 March 2026).
169.
PerrettSEPlimmerAShankarAG, et al.Prevalence of HCV in prisons in Wales, UK and the impact of moving to opt-out HCV testing. J Public Health2020; 42: 423–428. https://doi.org/10.1093/pubmed/fdaa022
MaciasJPalaciosRBClaroE, et al.High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Int2008; 28: 781–786. https://doi.org/10.1111/j.1478-3231.2008.01688.x
173.
FernandezNTowersCVWolfeL, et al.Sharing of snorting straws and hepatitis C virus infection in pregnant women. Obstet Gynecol2016; 128: 234–237. https://doi.org/10.1097/AOG.0000000000001507
174.
HaleyRWFischerRP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine (Baltim)2001; 80: 134–151. https://doi.org/10.1097/00005792-200103000-00006
175.
NealKRJonesDAKilleyD, et al.Risk factors for hepatitis C virus infection. A case-control study of blood donors in the Trent Region (UK). Epidemiol Infect1994; 112: 595–601. https://doi.org/10.1017/s0950268800051293
176.
SmithDJJordanAEFrankM, et al.Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis. BMC Infect Dis2016; 16: 471. https://doi.org/10.1186/s12879-016-1807-5
177.
HajarizadehBGrebelyJDoreGJ. Case definitions for acute hepatitis C virus infection: a systematic review. J Hepatol2012; 57: 1349–1360. https://doi.org/10.1016/j.jhep.2012.07.007
ThomsonECNastouliEMainJ, et al.Delayed anti-HCV antibody response in HIV-positive men acutely infected with HCV. AIDS2009; 23: 89–93. https://doi.org/10.1097/QAD.0b013e32831940a3
181.
KhanHHillAMainJ, et al.Can hepatitis C virus antigen testing replace ribonucleic acid polymearse chain reaction analysis for detecting hepatitis C virus? A systematic review. Open Forum Infect Dis2017; 4: ofw252. https://doi.org/10.1093/ofid/ofw252
182.
FreimanJMTranTMSchumacherSG, et al.Hepatitis C core antigen testing for diagnosis of hepatitis C virus infection: a systematic review and meta-analysis. Ann Intern Med2016; 165: 345–355. https://doi.org/10.7326/M16-0065
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
